The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety analysis of anlotinib combined with etoposide plus cisplatin/carboplatin as first-line therapy for extensive-stage small cell lung cancer (SCLC): The final results from a phase II single-arm trial.
 
Tiandong Kong
No Relationships to Disclose
 
Lu Chen
No Relationships to Disclose
 
Fangfang Duan
No Relationships to Disclose
 
Xiaoxia Hou
No Relationships to Disclose
 
Liuyan Wang
No Relationships to Disclose
 
Hanli Zhou
No Relationships to Disclose
 
Lanrong Wang
No Relationships to Disclose
 
Shanshan Hu
No Relationships to Disclose
 
Danna Liu
No Relationships to Disclose